INNOVENT BIOLOGICS INCINNOVENT BIOLOGICS INCINNOVENT BIOLOGICS INC

INNOVENT BIOLOGICS INC

No trades
See on Supercharts

1801 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. It operates through the following geographical segments: The People's Republic of China (PRC), the United States of America (USA), and Indonesia. The company was founded by De Chao Yu, Kevin Chen, and Scott M. Wheelwright on April 28, 2011 and is headquartered in Suzhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
1801 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company